Skip to main content

Patient Capital Management, LLC

Source: SEC Form 13F · as of Mar 2026

Patient Capital Management, LLC holds 1 biotech & pharma company tracked by BioSniper, totaling $69.0M in value as of Mar 2026 (SEC Form 13F).

Companies held

1

Total value held

$69.0M

BioSniper AIPage evidence connected

Prepared research question

What matters most for PRECIGEN, INC. (PGEN)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
PGENPRECIGEN, INC.17,817,387$69.0M

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.